142 related articles for article (PubMed ID: 20670084)
21. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
22. Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.
Hogan J; Avasare R; Radhakrishnan J
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1657-67. PubMed ID: 24832093
[TBL] [Abstract][Full Text] [Related]
23. Novel therapies of lupus nephritis.
Schieppati A; Remuzzi G
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):156-61. PubMed ID: 18277148
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
[TBL] [Abstract][Full Text] [Related]
25. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
26. [Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment].
Yamanaka R
Brain Nerve; 2009 Oct; 61(10):1155-64. PubMed ID: 19882942
[TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis: where are we now?
Lightstone L
Curr Opin Rheumatol; 2010 May; 22(3):252-6. PubMed ID: 20305561
[TBL] [Abstract][Full Text] [Related]
28. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.
Chamberlain MC
Neurology; 2015 Feb; 84(7):758-9. PubMed ID: 25688152
[No Abstract] [Full Text] [Related]
29. Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate.
Waldman MA; Callen JP
J Am Acad Dermatol; 2004 Aug; 51(2 Suppl):S124-30. PubMed ID: 15280831
[TBL] [Abstract][Full Text] [Related]
30. Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.
Yamanaka R; Homma J; Sano M; Tsuchiya N; Yajima N; Shinbo Y; Hasegawa A; Onda K; Tanaka R
Leuk Lymphoma; 2007 May; 48(5):1019-22. PubMed ID: 17487746
[No Abstract] [Full Text] [Related]
31. Cytomegalovirus colitis.
Sánchez Escuredo A; Grados Cànovas D; Ibernon Vilaró M; López Álvarez D; Moreno de Vega Lomo V; Navarro Díaz M; Romero R
Nefrologia; 2011; 31(1):119-20. PubMed ID: 21270929
[No Abstract] [Full Text] [Related]
32. [New treatments for systemic diseases].
Bader-Meunier B; Willems M
Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
[No Abstract] [Full Text] [Related]
33. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Wong ET; Tishler R; Barron L; Wu JK
Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
[TBL] [Abstract][Full Text] [Related]
34. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
[No Abstract] [Full Text] [Related]
35. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management.
Burnette BL; Jentoft MA; Porrata LF; Boyce TG; Witzig TE
J Clin Oncol; 2014 Mar; 32(7):e14-7. PubMed ID: 24395859
[No Abstract] [Full Text] [Related]
36. Treatment of lupus nephritis by mycophenolate mofetil.
Rabrenović V; Poskurica M; Kovacević Z; Nesić V; Savin M; Mitić B; Dimković N; Cucković C; Vujić D; Pljesa S; Perunicić-Peković G; Curić S; Mitić I; Ratković M; Marinković J; Jovanović D
Kidney Blood Press Res; 2010; 33(4):297-303. PubMed ID: 20664209
[TBL] [Abstract][Full Text] [Related]
37. [Lupus-nephritis--diagnosis and treatment].
Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
[TBL] [Abstract][Full Text] [Related]
38. Disseminated cryptococcosis as a complication of lupus nephritis.
Beji S; Hajji M; El Kateb H; Kosai I; Jebali H; Kheder R; Fatma LB; Rais L; Laameri L; Krid M; Zouaghi K
Saudi J Kidney Dis Transpl; 2017; 28(6):1435-1439. PubMed ID: 29265061
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
40. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
Suszek D; Wielosz E; Majdan M
Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
